Clin2
NCT07293910Possibly a fitRecruiting

Comparing stomach acid drugs for clearing H. pylori infection

HELICOBACTER PYLORI INFECTIONSHelicobacter InfectionHelicobacter Pylori Gastrointestinal Tract InfectionHelicobacter Pylori Infected Patients

Treatments studied

Part of Infections clinical trials.

This trial tests different combinations of stomach acid-reducing drugs, vitamin D or probiotics, to see which works best for clearing an H. pylori infection. H. pylori is a common stomach bacteria that can cause ulcers or stomach discomfort.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
132 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You are 18 to 79 years old.
  • You have a confirmed H. pylori infection (or you are known not to have it).
  • You are not pregnant or breastfeeding.
  • You have not taken antibiotics, acid-reducing drugs, or H2 blockers in the last month.
  • You have never had a previous H. pylori treatment, stomach surgery, stomach bleeding, or stomach cancer.
  • You do not have liver disease, kidney problems, or a current inflammatory disease.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07275827Recruiting· Phase 3
Testing 3 treatments for H. pylori infection

This study compares two different acid-reducing medications, given with or without zinc, to see which is safer and works best for treating H. pylori. All treatments are combined with two antibiotics.

Shibīn al Kawm
NCT06723197Recruiting· Phase 4
Comparing treatment lengths for H. pylori infection

This trial compares different lengths of treatment with two or four medications to see which works best for clearing H. pylori, a stomach bacteria that can cause ulcers. It is for people who have not been treated for this infection before.

Jinan, Shandong
NCT07750938Not yet recruiting· Phase 4
Better acid control for first-time H. pylori treatment

This study tests a new combination of medicines to treat H. pylori, a stomach infection that can cause ulcers. It aims to see if stronger acid suppression helps the antibiotics work better and clear the infection.

NCT07179159Recruiting
14-day stomach infection treatment study

This study compares two treatments for an H. pylori stomach infection: taking two medicines (vonoprazan and amoxicillin) versus taking four medicines. Both treatments are given for 14 days.

Jinan, Shandong
NCT07165444Recruiting
Comparing two acid-blocking drugs for H. pylori treatment

This trial tests if a newer acid-blocking medicine works better than a standard one when given with antibiotics and bismuth for treating H. pylori infection, a bacteria that can cause stomach ulcers. It is for adults who have not had treatment for H. pylori before.

Tanta, El-Gharbia
NCT07068607Recruiting· Phase 4
Comparing two treatments for H. pylori infection

This study tests whether a new stomach acid medicine called vonoprazan, combined with different antibiotics, works better than standard treatments to clear an H. pylori infection. It is for people who have never been treated for H. pylori and want to try a shorter, simpler treatment course.

Xi'an, Shaanxi

Hear when a new Helicobacter Infection trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.